Chinese Manufacturing Plants' Unsafe Conditions Exposed

The factories in question manufactured semaglutide and tirzepatide, the active ingredients in weight-loss medications from Novo Nordisk A/S and Eli Lilly & Co., for non-regulated custom-made versions. Despite lacking regulatory.....

Subscribe for Full Access!

Gain valuable sourcing and trade intelligence from our database of millions of data points spanning 20+ years!
Subscribe!
Share this Data